[HTML][HTML] Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of …

N Kakuta, R Nakano, A Nakano, Y Suzuki… - International Journal of …, 2020 - Elsevier
Objective To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano, Y Suzuki, T Masui… - 2020 - ginmu.naramed-u.ac.jp
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: predominance of CTX-M-15 and emergence of …

N Kakuta, R Nakano, A Nakano, Y Suzuki, T Masui… - 2020 - cabidigitallibrary.org
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods A …

[引用][C] Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of …

N Kakuta, R Nakano, A Nakano, Y Suzuki, T Masui… - 2021 - ci.nii.ac.jp
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano, Y Suzuki, T Masui… - 2020 - 52.69.102.178
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano, Y Suzuki… - International Journal of …, 2020 - ijidonline.com
Objective To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano, Y Suzuki, T Masui… - (No Title) - cir.nii.ac.jp
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano… - International …, 2020 - tohoku.elsevierpure.com
Objective: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. Methods: A …

Molecular characteristics of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Japan: Predominance of CTX-M-15 and emergence of hypervirulent …

N Kakuta, R Nakano, A Nakano, Y Suzuki… - … Journal of Infectious …, 2020 - europepmc.org
OBJECTIVE: To provide data on the molecular characteristics of extended-spectrum β-
lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates in Japan. METHODS …